Intellective Bio.
Press Releases
Press Releases
Jun 11,2024
News | First Commercial Production Project Receives NMPA Approval
Chime Biologics-supported Sapalizumab production facility achieves NMPA approval, initiating commercialization and highlighting Intellective Bio's commitment to quality and compliance with GMP standards.
Learn More
Jun 11,2024
Intellective Bio has reached a strategic cooperation with the three major commercial banks
Intellective Biologics secures a strategic cooperation with Agricultural Bank, Bank of China, and Shanghai Pudong Development Bank, marking a significant 2 billion RMB investment for the construction of a nationwide bioproduct base project.
Learn More
Apr 19,2021
China Future Healthcare Rankings 2020-2021-Top 100 Biomedicine Companies
Intellective Bio is proudly featured among China's top healthcare companies, highlighting its significant contributions to the biomedicine industry in the 2020-2021 rankings.
Learn More
Nov 02,2020
Rising Star of China Biomedicine CDMO Enterprises in 2020
Celebrating its rapid ascent in the biopharmaceutical sector, Intellective Bio earns the prestigious title of Rising Star among China's CDMO enterprises for 2020.
Learn More
Find out how we can contribute to your success!
TOP
Copyright © Intellective Bio. All Rights Reserved ICP:苏ICP备19044439号-1